277 related articles for article (PubMed ID: 18586671)
1. TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.
Mahoney DJ; Mikecz K; Ali T; Mabilleau G; Benayahu D; Plaas A; Milner CM; Day AJ; Sabokbar A
J Biol Chem; 2008 Sep; 283(38):25952-62. PubMed ID: 18586671
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
3. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T; Kufner V; Vukičević S
Front Immunol; 2022; 13():869422. PubMed ID: 35558080
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor alpha-stimulated gene-6 inhibits osteoblastic differentiation of human mesenchymal stem cells induced by osteogenic differentiation medium and BMP-2.
Tsukahara S; Ikeda R; Goto S; Yoshida K; Mitsumori R; Sakamoto Y; Tajima A; Yokoyama T; Toh S; Furukawa K; Inoue I
Biochem J; 2006 Sep; 398(3):595-603. PubMed ID: 16771708
[TBL] [Abstract][Full Text] [Related]
5. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
[TBL] [Abstract][Full Text] [Related]
7. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.
Usui M; Xing L; Drissi H; Zuscik M; O'Keefe R; Chen D; Boyce BF
J Bone Miner Res; 2008 Mar; 23(3):314-25. PubMed ID: 17967138
[TBL] [Abstract][Full Text] [Related]
8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
9. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.
Subramaniam M; Gorny G; Johnsen SA; Monroe DG; Evans GL; Fraser DG; Rickard DJ; Rasmussen K; van Deursen JM; Turner RT; Oursler MJ; Spelsberg TC
Mol Cell Biol; 2005 Feb; 25(3):1191-9. PubMed ID: 15657444
[TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanisms of osteoblast and osteoclast differentiation.
Katagiri T; Takahashi N
Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro.
Gazzerro E; Deregowski V; Vaira S; Canalis E
Endocrinology; 2005 Sep; 146(9):3875-82. PubMed ID: 15919755
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
13. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.
Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N
Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
[TBL] [Abstract][Full Text] [Related]
15. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
16. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
[TBL] [Abstract][Full Text] [Related]
17. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
20. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
